Insider Transactions last 24 months for Ultragenyx Pharmaceutical Inc.  -  NSDQ: RARE

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Huizenga Theodore AlanSVP, Chief Accounting Officer09/18/2025DSDirectCOM64$29.17$1,866.8850,242
Parschauer Karah HerdmanEVP and Chief Legal Officer09/12/2025DSDirectCOM2,450$31.17$76,366.5073,271
Huizenga Theodore AlanSVP, Chief Accounting Officer09/05/2025DSDirectCOM84$31.39$2,636.7650,306
Sanders Corazon (Corsee) D.Director06/20/2025DSDirectCOM2,405$37.39$89,922.9515,344
Ray AmritDirector05/15/2025AADirectCOM5,740$0.00$0.0023,365
Dunsire DeborahDirector05/15/2025AADirectCOM5,740$0.00$0.0030,815
Fust Matthew KDirector05/15/2025AADirectCOM5,740$0.00$0.0025,945
Narachi MichaelDirector05/15/2025AADirectCOM5,740$0.00$0.0032,690
Sanders Corazon (Corsee) D.Director05/15/2025AADirectCOM5,740$0.00$0.0017,749
Welch Daniel GDirector05/15/2025AADirectCOM5,740$0.00$0.0032,690
Suliman ShehnaazDirector05/15/2025AADirectCOM5,740$0.00$0.0025,940
Crombez EricEVP and Chief Medical Officer05/05/2025DSDirectCOM520$39.24$20,404.8071,530
Crombez EricEVP and Chief Medical Officer04/21/2025DSDirectCOM242$35.11$8,496.6271,680
Horn HowardChief Financial Officer03/06/2025DSDirectCOM1,785$40.40$72,114.00106,169
Huizenga Theodore AlanSVP, Chief Accounting Officer03/03/2025DFDirectCOM141$42.92$6,051.7250,124
Huizenga Theodore AlanSVP, Chief Accounting Officer03/03/2025DSDirectCOM967$42.10$40,710.7050,265
Huang Dennis KarlSee Remarks03/03/2025DFDirectCOM1,348$42.92$57,856.16114,591
Harris ErikEVP & Chief Commercial Officer03/03/2025DSDirectCOM15,103$42.10$635,836.3087,855
Kakkis Emil DPresident & CEO03/03/2025DSDirectCOM73,434$42.10$3,091,571.40641,731
Pinion John RichardSee Remarks03/03/2025DFDirectCOM31$42.92$1,330.52108,428
Pinion John RichardSee Remarks03/03/2025DSDirectCOM14,439$42.10$607,881.90107,766
Crombez EricEVP and Chief Medical Officer03/03/2025DSDirectCOM8,945$42.10$376,584.5071,922
Parschauer Karah HerdmanEVP and Chief Legal Officer03/03/2025DSDirectCOM12,846$42.10$540,816.6075,287
Kassberg Thomas RichardCBO & EVP03/03/2025DFDirectCOM508$42.92$21,803.36264,730
Kassberg Thomas RichardCBO & EVP03/03/2025DSDirectCOM6,028$42.10$253,778.80265,238
1   2  3  4  5  Next Last  You are at page 1 of 5 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel